lobbying_activities: 3477476

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3477476	60151fb0-1a65-4941-b483-33d3b8185259	Q4	THE PETRIZZO GROUP, INC.	305932	AKEBIA THERAPEUTICS, INC.	2025	fourth_quarter	MMM	Provided legislative advocacy specific to the payment of innovative drugs, such as phosphate binders and anemia management drugs in the Medicare End-Stage Renal Dialysis Prospective Payment System (ESRD PPS).	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE	45000		0	0	2025-12-31T10:35:49-05:00